Transjugular Random Renal Biopsy: How We Do It

Biopsy is the gold standard in the diagnosis of diffuse kidney disease.[1] Percutaneous random renal biopsy is a safe and effective method to obtain renal tissue for the diagnosis of diffuse kidney disease.[2] Patients with diffuse kidney disease and multiple comorbidities (morbid obesity, thrombocytopenia, coagulopathies, high blood pressure) may be at higher risk of having a bleeding complication during or after a percutaneous random renal biopsy.[1] If a renal biopsy is imperative to decide a therapeutic approach in high-risk patients, a transjugular renal biopsy (TJRB) may be a safer option.[3]

Halimi et al developed a bleeding risk score for patients with an indication for random renal biopsy.[4] At our institution, we recommend TJRB in patients with a calculated bleeding risk score higher than 15. The purpose of this article is to describe patient selection criteria and procedure techniques for TJRB at our center.

Publikationsverlauf

Artikel online veröffentlicht:
07. November 2024

• References

• 1 Schnuelle P. Renal biopsy for diagnosis in kidney disease: indication, technique, and safety. J Clin Med 2023; 12 (19) 6424
• 2 Uppot RN, Harisinghani MG, Gervais DA. Imaging-guided percutaneous renal biopsy: rationale and approach. AJR Am J Roentgenol 2010; 194 (06) 1443-1449
• 3 Mal F, Meyrier A, Callard P. et al. Transjugular renal biopsy. Lancet 1990; 335 (8704): 1512-1513
• 4 Halimi JM, Gatault P, Longuet H. et al. Major bleeding of transjugular native kidney biopsies. A French nationwide cohort study. Kidney Int Rep 2021; 6 (10) 2594-2603
• 5 Abbott KC, Musio FM, Chung EM, Lomis NN, Lane JD, Yuan CM. Transjugular renal biopsy in high-risk patients: an American case series. BMC Nephrol 2002; 3: 5
• 6 Misra S, Gyamlani G, Swaminathan S. et al. Safety and diagnostic yield of transjugular renal biopsy. J Vasc Interv Radiol 2008; 19 (04) 546-551